Dermatology Medical News about Onychomycosis

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis
Clinical and Experimental Dermatology, 11/02/09

Mesa AC et al. – The aetiological agents of onychomycosis that found differ from those found in other countries, suggesting that the heat and humidity of the Colombian climate could favour yeast nail infections. The lowest MICs for Candida species may be explained by emerging resistant strains. Against dermatophytes, the lowest MICs were obtained with terbinafine, followed by voriconazole. MIC values for the evaluated agents were higher for non–dermatophyte filamentous fungi than for other fungi. As MIC breakpoints have not yet been established for onychomycosis therapies, it remains unclear if in vitro activities of antifungal drugs are predictive of clinical outcome.

<< Previous
Management of acne vulgaris: an evidence-based update

Next >>
Comparators, study duration, outcome measures and sponsorship in...

Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study
British Journal of Dermatology, 10/07/09 Relevance Score: 87%

Onychomycosis caused by Phaeoacremonium parasiticum: first case report
Mycoses, 10/01/09 Relevance Score: 85%